Literature DB >> 35545942

The Immune System in Hypertension: a Lost Shaker of Salt 2021 Lewis K. Dahl Memorial Lecture.

Xiaohan Lu1, Steven D Crowley1.   

Abstract

The seminal observations of Dr Lewis Dahl regarding renal mechanisms of hypertension remain highly relevant in light of more recent experiments showing that immune system dysfunction contributes to hypertension pathogenesis. Dr Dahl established that inappropriate salt retention in the kidney plays a central role via Ohm's Law in permitting blood pressure elevation. Nevertheless, inflammatory cytokines whose expression is induced in the early stages of hypertension can alter renal blood flow and sodium transporter expression and activity to foster renal sodium retention. By elaborating these cytokines and reactive oxygen species, myeloid cells and T lymphocytes can connect systemic inflammatory signals to aberrant kidney functions that allow sustained hypertension. By activating T lymphocytes, antigen-presenting cells such as dendritic cells represent an afferent sensing mechanism triggering T cell activation, cytokine generation, and renal salt and water reabsorption. Manipulating these inflammatory signals to attenuate hypertension without causing prohibitive systemic immunosuppression will pose a challenge, but disrupting actions of inflammatory mediators locally within the kidney may offer a path through which to target immune-mediated mechanisms of hypertension while capitalizing on Dr Dahl's key recognition of the kidney's importance in blood pressure regulation.

Entities:  

Keywords:  blood pressure; hypertension; immune system; kidney; sodium transporters

Mesh:

Substances:

Year:  2022        PMID: 35545942      PMCID: PMC9248984          DOI: 10.1161/HYPERTENSIONAHA.122.18554

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   9.897


  112 in total

1.  Myeloid Suppressor Cells Accumulate and Regulate Blood Pressure in Hypertension.

Authors:  Kandarp H Shah; Peng Shi; Jorge F Giani; Tea Janjulia; Ellen A Bernstein; You Li; Tuantuan Zhao; David G Harrison; Kenneth E Bernstein; Xiao Z Shen
Journal:  Circ Res       Date:  2015-08-20       Impact factor: 17.367

2.  Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.

Authors:  Paul M Ridker; Brendan M Everett; Tom Thuren; Jean G MacFadyen; William H Chang; Christie Ballantyne; Francisco Fonseca; Jose Nicolau; Wolfgang Koenig; Stefan D Anker; John J P Kastelein; Jan H Cornel; Prem Pais; Daniel Pella; Jacques Genest; Renata Cifkova; Alberto Lorenzatti; Tamas Forster; Zhanna Kobalava; Luminita Vida-Simiti; Marcus Flather; Hiroaki Shimokawa; Hisao Ogawa; Mikael Dellborg; Paulo R F Rossi; Roland P T Troquay; Peter Libby; Robert J Glynn
Journal:  N Engl J Med       Date:  2017-08-27       Impact factor: 91.245

3.  Restraining immunity could lower high blood pressure.

Authors:  Mitch Leslie
Journal:  Science       Date:  2018-03-02       Impact factor: 47.728

4.  TNFR1-deficient mice display altered blood pressure and renal responses to ANG II infusion.

Authors:  Chun Cheng Andy Chen; Paulina L Pedraza; Shoujin Hao; Charles T Stier; Nicholas R Ferreri
Journal:  Am J Physiol Renal Physiol       Date:  2010-08-25

5.  Rag1-null Dahl SS rats reveal that adaptive immune mechanisms exacerbate high protein-induced hypertension and renal injury.

Authors:  Justine M Abais-Battad; Hayley Lund; Daniel J Fehrenbach; John Henry Dasinger; David L Mattson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2018-03-14       Impact factor: 3.619

6.  Interleukin-1beta, but not interleukin-6, enhances renal and systemic endothelin production in vivo.

Authors:  Erika I Boesen; Jennifer M Sasser; Mohamed A Saleh; William A Potter; Mandy Woods; Timothy D Warner; Jennifer S Pollock; David M Pollock
Journal:  Am J Physiol Renal Physiol       Date:  2008-06-04

7.  Experimental induction of salt-sensitive hypertension is associated with lymphocyte proliferative response to HSP70.

Authors:  Gustavo Parra; Yasmir Quiroz; Jenny Salazar; Yanauri Bravo; Hector Pons; Maribel Chavez; Richard J Johnson; Bernardo Rodriguez-Iturbe
Journal:  Kidney Int Suppl       Date:  2008-12       Impact factor: 10.545

8.  Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction.

Authors:  Meena S Madhur; Heinrich E Lob; Louise A McCann; Yoichiro Iwakura; Yelena Blinder; Tomasz J Guzik; David G Harrison
Journal:  Hypertension       Date:  2009-12-28       Impact factor: 10.190

9.  Dendritic Cell Amiloride-Sensitive Channels Mediate Sodium-Induced Inflammation and Hypertension.

Authors:  Natalia R Barbaro; Jason D Foss; Dmytro O Kryshtal; Nikita Tsyba; Shivani Kumaresan; Liang Xiao; Raymond L Mernaugh; Hana A Itani; Roxana Loperena; Wei Chen; Sergey Dikalov; Jens M Titze; Bjorn C Knollmann; David G Harrison; Annet Kirabo
Journal:  Cell Rep       Date:  2017-10-24       Impact factor: 9.423

10.  Salt-responsive gut commensal modulates TH17 axis and disease.

Authors:  Nicola Wilck; Mariana G Matus; Sean M Kearney; Scott W Olesen; Kristoffer Forslund; Hendrik Bartolomaeus; Stefanie Haase; Anja Mähler; András Balogh; Lajos Markó; Olga Vvedenskaya; Friedrich H Kleiner; Dmitry Tsvetkov; Lars Klug; Paul I Costea; Shinichi Sunagawa; Lisa Maier; Natalia Rakova; Valentin Schatz; Patrick Neubert; Christian Frätzer; Alexander Krannich; Maik Gollasch; Diana A Grohme; Beatriz F Côrte-Real; Roman G Gerlach; Marijana Basic; Athanasios Typas; Chuan Wu; Jens M Titze; Jonathan Jantsch; Michael Boschmann; Ralf Dechend; Markus Kleinewietfeld; Stefan Kempa; Peer Bork; Ralf A Linker; Eric J Alm; Dominik N Müller
Journal:  Nature       Date:  2017-11-15       Impact factor: 49.962

View more
  1 in total

Review 1.  Genetic Modifications to Alter Blood Pressure Level.

Authors:  Hiroki Ohara; Toru Nabika
Journal:  Biomedicines       Date:  2022-08-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.